Status:
COMPLETED
Whole Genome Sequencing of Tuberculosis for Disease Control in Madagascar
Lead Sponsor:
Institut Pasteur de Madagascar
Collaborating Sponsors:
The National Tuberculosis Program, Madagascar
Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Conditions:
Tuberculosis
Eligibility:
All Genders
Phase:
NA
Brief Summary
Tuberculosis (TB) whole genome sequencing (WGS) allows outbreak identification and disease transmission tracking. It is hypothesized that prospective WGS-guided epidemiological investigations improve...
Eligibility Criteria
Inclusion
- Subjects suspected TB
- subject living in the study area
Exclusion
- unable to take a sputum sample
Key Trial Info
Start Date :
May 16 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
98362 Patients enrolled
Trial Details
Trial ID
NCT05406453
Start Date
May 16 2022
End Date
June 30 2024
Last Update
October 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fokontany Vohibato
Vohibato, Madagascar